Changes in and Determinants of Quality of Life in Patients With Advanced Non-Small-Cell Lung Cancer Undergoing Initial Chemotherapy

10.1097/jnr.0000000000000148

Yu-Lee Dai；Cheng-Ta Yang；Kang-Hua Chen；Siew-Tzuh Tang

quality of life ； chemotherapy ； advanced non-small-cell lung cancer

The Journal of Nursing Research

25卷3期（2017 / 06 / 01）

203 - 215

英文

Background: Few studies have evaluated completely the changes in quality of life (QOL) that occur from pretreatment through the first four consecutive cycles of chemotherapy or determined its determinants in patients with advanced non-small-cell lung cancer (NSCLC). Purpose: The aim of this study was to explore the changes to and determinants of QOL in patients with advanced NSCLC under initial chemotherapy from pretreatment through Cycle 4 of chemotherapy. Methods: The QOL of 139 patients with advanced NSCLC was assessed from prechemotherapy through Cycle 4 of chemotherapy. Changes to and determinants of QOL were evaluated using multivariate linear regression, which used generalized estimation equation models. Results: No significant changes were observed in the global QOL or the physical, role, emotional, or cognitive functional domains of QOL during the course of chemotherapy. However, the social functional domain of QOL improved significantly at Cycle 3 in comparison with the prechemotherapy values. Better global QOL was determined as better performance status, less frequent physical symptoms, and less severe anxiety and depressive symptoms. Important determinants of better QOL in the five functional domains included younger age, better performance status, less frequent physical symptoms, less severe anxiety and depressive symptoms, and weaker perceived social support. Furthermore, patients who achieved a partial response after chemotherapy enjoyed stronger improvements in global QOL and the QOL emotional functional domain than those who did not. Conclusions: To help patients with advanced NSCLC optimize their QOL, healthcare professionals should enhance their ability to identify patients who are at elevated risk of poor QOL throughout the course of chemotherapy and to appropriately detect and manage the related physical symptoms and side effects, strengthen patients' social support, and lessen the anxiety and depressive symptoms of patients.

1. National Comprehensive Cancer Network. (2014). NCCN clinical practice guidelines in oncology (NCCN guidelines)-Non-small cell lung cancer (version 4). Retrieved from https://www.nccn.org/store/login/login.aspx?ReturnURL=http://www.nccn.org/professionals/physician_gls/pdf/lung_screening.pdf
2. World Health Organization. (2012). Cancer. Retrieved from http://www.who.int/mediacentre/factsheets/fs297/en/
3. Health Promotion Administration,Ministry of Health and Welfare Taiwan. (2015). Cancer registry annual report, 2012 Taiwan. Retrieved from http://www.hpa.gov.tw/BHPNet/Portal/File/StatisticsFile/201504290915220898/101%E5%B9%B4%E7%99%8C%E7%97%87%E7%99%BB%E8%A8%98%E5%B9%B4%E5%A0%B1.pdf
4. Bloechl-Daum, B.,Deuson, R. R.,Mavros, P.,Hansen, M.,Herrstedt, J.(2006).Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment.Journal of Clinical Oncology,24(27),4472-4478.
5. Burton, P.,Gurrin, L.,Sly, P.(1998).Extending the simple linear regression model to account for correlated responses: An introduction to generalized estimating equations and multi-level mixed modeling.Statistics in Medicine,17(11),1261-1291.
6. Cao, J.,Wang, Y.,Zhang, L.,Ma, L.(2011).Investigation of the change of quality of life and depression in lung cancer patients before and after chemotherapy.Chinese Journal of Lung Cancer,14(4),358-361.
7. Chen, L. K.,Liang, Y.,Yang, Q. Y.,Xu, F.,Zhou, N. N.,Xu, G. C.,Wei, W. D.(2012).Triplet platinum-based combination sequential chemotherapy improves survival outcome and quality of life of advanced non-small cell lung cancer patients.Asian Pacific Journal of Cancer Prevention,13(5),1863-1867.
8. Chen, M. L.,Yu, C. T.,Yang, C. H.(2008).Sleep disturbances and quality of life in lung cancer patients undergoing chemotherapy.Lung Cancer,62(3),391-400.
9. Chie, W. C.,Yang, C. H.,Hsu, C.,Yang, P. C.(2004).Quality of life of lung cancer patients: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-LC13.Quality of Life Research,13(1),257-262.
10. Cohen, S.,Wills, T. A.(1985).Stress, social support, and the buffering hypothesis.Psychological Bulletin,98(2),310-357.
11. Dai, Y. L.,Chen, C. H.,Yang, C. T.,Chen, K. H.,Chiang, M. C.,Tang, S. T.(2015).A meta-analysis of changes and determinants of quality of life in advanced non-small cell lung cancer patients undergoing chemotherapy.Journal of Cancer Research and Practice,2(3),224-233.
12. de Oliveira, P. I.,Pereira, C. A.,Belasco, A. G.,Bettencourt, A. R.(2013).Comparison of the quality of life among persons with lung cancer, before and after the chemotherapy treatment.Revista Latino-Americana de Enfermagem,21(3),787-794.
13. Dunn, O. J.(1961).Multiple comparisons among means.Journal of the American Statistical Association,56(293),52-64.
14. Fløtten, Ø.,Grønberg, B. H.,Bremnes, R.,Amundsen, T.,Sundstrøm, S.,Rolke, H.,von Plessen, C.(2012).Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Group.British Journal of Cancer,107(3),442-447.
15. Helsing, M.,Bergman, B.,Thaning, L.,Hero, U.(1998).Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicenter randomised phase III trial. Joint Lung Cancer Study Group.European Journal of Cancer,34(7),1036-1044.
16. Henoch, I.,Bergman, B.,Gustafsson, M.,Gaston-Johansson, F.,Danielson, E.(2007).The impact of symptoms, coping capacity, and social support on quality of life experience over time in patients with lung cancer.Journal of Pain and Symptom Management,34(4),370-379.
17. Hermann, C. P.,Looney, S. W.(2011).Determinants of quality of life in patients near the end of life: A longitudinal perspective.Oncology Nursing Forum,38(1),23-31.
18. Iyer, S.,Taylor-Stokes, G.,Roughley, A.(2013).Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and Germany.Lung Cancer,81(2),288-293.
19. Juang, Y. Y.,Lin, C. R.,Yang, T. Y.,Chin, Y. F.,Wang, B. H.(2013).Depressive disorders in patients with cancer.Formosan Journal of Medicine,17(2),155-162.
20. Kaptein, A. A.,Yamaoka, K.,Snoei, L.,Kobayashi, K.,Uchida, Y.,van der Kloot, W. A.,IRabe, K.(2011).Illness perceptions and quality of life in Japanese and Dutch patients with non-smallcell lung cancer.Lung Cancer,72(3),384-390.
21. Kim, H. S.,Sherman, D. K.,Taylor, S. E.(2008).Culture and social support.The American Psychologist,63(6),518-526.
22. Kroenke, C. H.,Kwan, M. L.,Neugut, A.I.,Ergas, I. J.,Wright, J. D.,Caan, B. J.,Kushi, L. H.(2013).Social networks, social support mechanisms, and quality of life after breast cancer diagnosis.Breast Cancer Research and Treatment,139(2),515-527.
23. Liang, J. J.、Jiang, Y. L.、Li, Y. B.(2007)。Relative research between social supports and quality of life of patients with lung cancer in period。Modern Nursing，13(16)，1491-1497。
24. Liu, Y. F.、Yen, M. C.、Chen, L. C.(2009)。A longitudinal study of lung cancer patients during chemotherapy of quality of life。Shanghai Nursing，9(1)，30-34。
25. Luszczynska, A.,Pawlowska, I.,Cieslak, R.,Knoll, N.,Scholz, U.(2013).Social support and quality of life among lung cancer patients: A systematic review.Psycho-oncology,22(10),2160-2168.
26. Matsuda, A.,Yamaoka, K.,Tango, T.(2012).Quality of life in advanced non-small cell lung cancer patients receiving palliative chemotherapy: Ameta-analysis of randomized controlled trials.Experimental and Therapeutic Medicine,3(1),134-140.
27. Mitchell, A. J.,Meader, N.,Symonds, P.(2010).Diagnostic validity of the Hospital Anxiety and Depression Scale (HADS) in cancer and palliative settings: A meta-analysis.Journal of Affective Disorders,126(3),335-348.
28. Mojaverian, T.,Kim, H. S.(2013).Interpreting a helping hand: Cultural variation in the effectiveness of solicited and unsolicited social support.Personality & Social Psychology Bulletin,39(1),88-99.
29. Pan, Y.,Xu, Y. H.,Wang, W. M.,Zhu, J.(2011).Analysis of influencing factors for quality of life of patients with non-small cell lung cancer.Journal of Shanghai Jiaotong University (Medical Science),31(3),339-342.
30. Pat, K.,Dooms, C.,Vansteenkiste, J.(2008).Systematic review of symptom control and quality of life in studies on chemotherapy for advanced non-small cell lung cancer: How CONSORTed are the data?.Lung Cancer,62(1),126-138.
31. Rodríguez, A.M.,Mayo, N. E.,Gagnon, B.(2013).Independent contributors to overall quality of life in people with advanced cancer.British Journal of Cancer,108(9),1790-1800.
32. Sherbourne, C. D.,Stewart, A. L.(1991).The MOS social support survey.Social Science & Medicine,32(6),705-714.
33. Spiro, S. G.,Rudd, R. M.,Souhami, R. L.,Brown, J.,Fairlamb, D. J.,Gower, N. H.,Big Lung Trial participants(2004).Chemotherapy versus supportive care in advanced non-small cell lung cancer: Improved survival without detriment to quality of life.Thorax,59(10),828-836.
34. Tang, S. T.,Liu, T. W.,Tsai, C. M.,Wang, C. H.,Chang, G. C.,Liu, L. N.(2008).Patient awareness of prognosis, patient-family caregiver congruence on the preferred place of death, and caregiving burden of families contribute to the quality of life for terminally ill cancer patients in Taiwan.Psycho-oncology,17(12),1202-1209.
35. Taylor, S. E.,Sherman, D. K.,Kim, H.S.,Jarcho, J.,Takagi, K.,Dunagan, M. S.(2004).Culture and social support: Who seeks it and why?.Journal of Personality and Social Psychology,87(3),354-362.
36. Vodermaier, A.,Linden, W.,Siu, C.(2009).Screening for emotional distress in cancer patients: A systematic review of assessment instruments.Journal of the National Cancer Institute,101(21),1464-1488.
37. Wilson, I. B.,Cleary, P. D.(1995).Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes.Journal of the American Medical Association,273(1),59-65.
38. Wu, C. Y.(2005).Taichung, Taiwan, ROC,China Medical University.
39. Zhan, Z. Y.(2008).Nanchang University.
40. Zigmond, A. S.,Snaith, R. P.(1983).The hospital anxiety and depression scale.Acta Psychiatrica Scandinavica,67(6),361-370.

1. Dhuha Youssef WAZQAR(2019).Cognitive Dysfunction and Its Predictors in Adult Patients With Cancer Receiving Chemotherapy: A Cross-Sectional Correlational Study.The Journal of Nursing Research,27(6),1-8.
2. Yongxia SONG,Xiaoqing LV,Tian ZHANG,Qunhui LIU,Jingfang HONG,Hongye HE(2019).Supportive Care Needs of Patients With Lung Cancer in Mainland China: A Cross-Sectional Study.The Journal of Nursing Research,27(6),1-9.
3. Yun-Hsiang LEE,Woung-Ru TANG,Pei-Kwei TSAY,Jui-Chun CHAN,Hui-Hsuan SHIH,Chien-Ying LIU(2019).A Correlational Study of Skin Toxicity and Quality of Life in Patients With Advanced Lung Cancer Receiving Targeted Therapy.The Journal of Nursing Research,27(6),1-9.